TITLE

Bisphosphonate use and the risk of adverse jaw outcomes: A Medical Claims Study of 714,217 People

AUTHOR(S)
Cartsos, Vassiliki M.; Zhu, Shao; Zavras, Athanasios I.
PUB. DATE
January 2008
SOURCE
Journal of the American Dental Association (JADA);Jan2008, Vol. 139 Issue 1, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study that explores the risk of osteonecrosis of the jaw (ONJ) among users of oral bisphosphonates (BPs) or the magnitude of the risk among users of intravenous (IV) BPs. Results reveal that oral administration of BPs reduces the risk of negative bone outcomes, while IV administration increases the risk of adverse jaw outcomes or surgery. The study also shows that patients receiving IV BPs has a fourfold increased risk of having inflammatory jaw conditions.
ACCESSION #
28655245

 

Related Articles

  • Beware of bisphosphonates and jaw disorder. Hitchens, Kathy // Drug Topics;11/20/2006, Vol. 150 Issue 22, p24 

    The article discusses the position paper on bisphosphonate-related osteonecrosis of the jaw which was released by the American Association of Oral and Maxillofacial Surgeons. The paper is designed to identify that bisphosphonates have a side effect and how to manage them. According to the...

  • Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. Frieder Bauss; Thomas Pfister; Socrates Papapoulos // Journal of Bone & Mineral Metabolism;Jul2008, Vol. 26 Issue 4, p406 

    Abstract  Intravenous bisphosphonates may be involved in the development of osteonecrosis of the jaw (ONJ). However, a mechanistic causality has not been demonstrated. To evaluate whether there is higher drug uptake by the jaw versus other bones that might be involved in ONJ pathogenesis,...

  • Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Chiandussi, S.; Biasouo, M.; Dore, F.; Cavalli, F.; Cova, M. A.; Di Lenarda, R. // Dentomaxillofacial Radiology;Jul2006, Vol. 35 Issue 4, p236 

    Objectives: It is important to recognize osteonecrosis of the jaws in patients treated with bisphosphonates because an early diagnosis can make a significant difference to the outcome of the disease. The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis...

  • Osteonecrosis of the Jaw – Do Bisphosphonates Pose a Risk? Bilezikian, John P. // New England Journal of Medicine;11/30/2006, Vol. 355 Issue 22, p2278 

    The article presents the author's views regarding the use of bisphosphonates therapy for patients with osteonecrosis of the jaw. He says that although more research is still needed to clarify the risks of bisphosphonates therapy, its benefits clearly outweigh whatever small risk might be...

  • Bisphosphonates, Phossy Jaw, and Bisphosphonate-Related Osteonecrosis of the Jaw. LEWIS, DAVID M. // Oklahoma Dental Association Journal;Jul2011, Vol. 102 Issue 5, p36 

    The article offers information on bisphosphonates, phossy jaw and bisphosphonate-related osteonecrosis of the jaw (BRONJ). It states that bisphosphonates were first synthesized in 1868 and became valuable in the textile, fertilizer and oil industries due to their ability to inhibit calcium...

  • Evolution and Etiopathogenesis of Bisphosphonates Induced Osteonecrosis of the Jaw. Kumar, Vijay; Kant Sinha, Raman // North American Journal of Medical Sciences;Apr2013, Vol. 5 Issue 4, p260 

    Bisphosphonates (BPs) is widely used as the first line of treatment choice for osteoporosis, Paget's disease of bone, bone cancer metastasis and hypercalcemia of malignancy. BPs induced osteonecrosis of the jaw (ONJ) is a relatively rare but severe clinical condition cited in English literature...

  • Bisphosphonate-related osteonecrosis of the jaws. Kumar, Vandana; Pass, Barry; Guttenberg, Steven A.; Ludlow, John; Emery, Robert W.; Tyndall, Donald A.; Padilla, Ricordo J. // Journal of the American Dental Association (JADA);May2007, Vol. 138 Issue 5, p602 

    The article reports on several cases with contrasting treatment outcomes and morbidity in patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ). The authors demonstrate the usefulness of dental diagnostic imaging in the detection and management of BRONJ. The authors also discuss...

  • Anatomic Factors related to bisphosphonate Osteonecrosis of the Jaws: a Portuguese retrospective study. ÁLVARES FURTADO, Ivo; CALDAS, Cecília FRANCO; LANÇA, Fernanda; SALVADO E. SILVA, Francisco // Acta Medica Portuguesa;Mar/Apr2012, Vol. 25 Issue 2, p106 

    Aims: The objectives of this study of bisphosphonate-related osteonecrosis of the jaws (BRONJ) were to determine local distribution, possible anatomically associated or determinant factors and other bone involvement of the disease, contributing with this new data towards the establishment of its...

  • Bisphosphonate-associated osteonecrosis of the jaw. Basu, Neil; Reid, David M. // Menopause International;Jun2007, Vol. 13 Issue 2, p56 

    The term 'osteonecrosis of the jaw' is typically used to describe the exposure of bone within the oral cavity. These lesions are often painful and can result in pathological fracture and disfigurement in severe cases. Infection and dental extractions commonly precede presentation, although...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics